Although Pim-1 or Pim-2 can contribute to lymphoid transformation when overexpressed, the physiologic role of these kinases in the immune response is uncertain. We now report that T cells from Pim-1(-/-)Pim-2(-/-) animals display an unexpected sensitivity to the immunosuppressant rapamycin. Cytokine-induced Pim-1 and Pim-2 promote the rapamycin-resistant survival of lymphocytes. The endogenous function of the Pim kinases was not restricted to the regulation of cell survival. Like the rapamycin target TOR, the Pim kinases also contribute to the regulation of lymphocyte growth and proliferation. Although rapamycin has a minimal effect on wild-type T cell expansion in vitro and in vivo, it completely suppresses the response of Pim-1(...
The established role for phosphatidylinositol (3,4,5) triphosphate (PI(3,4,5)P3) signaling pathways ...
Currently, there is no efficient therapy for patients with peripheral T cell lymphoma (PTCL). The Pr...
Thesis (M.A.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Author...
Growth factors regulate cell growth and survival through the activation of intracellular signal tran...
1. T-cell proliferation is critical for mounting an effective adaptive immune response. It is regula...
The Akt kinases promote hematopoietic cell growth and accumulation through phosphorylation of apopto...
The established role for phosphatidylinositol (3,4,5) triphosphate (PI(3,4,5)P3) signaling pathways ...
The immunosuppressant rapamycin (RAP) is a potent inhibitor of the entry of interleukin (IL)-2-stimu...
The phosphatidylinositol-3-OH kinase [PI(3)K] pathway is frequently activated in human cancers and r...
The phosphatidylinositol-3-OH kinase [PI(3)K] pathway is frequently activated in human cancers and r...
In T lymphocytes, the hematopoietic cytokine interleukin-2 (IL-2) uses phosphatidylinositol 3-kinase...
In T lymphocytes, the hematopoietic cytokine interleukin-2 (IL-2) uses phosphatidylinositol 3-kinase...
The macrolide rapamycin (RAP) is a potent inhibitor of interleukin-2 (IL- 2)-induced T-cell prolifer...
The established role for phosphatidylinositol (3,4,5) triphosphate (PI(3,4,5)P-3) signaling pathways...
<div><p>Currently, there is no efficient therapy for patients with peripheral T cell lymphoma (PTCL)...
The established role for phosphatidylinositol (3,4,5) triphosphate (PI(3,4,5)P3) signaling pathways ...
Currently, there is no efficient therapy for patients with peripheral T cell lymphoma (PTCL). The Pr...
Thesis (M.A.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Author...
Growth factors regulate cell growth and survival through the activation of intracellular signal tran...
1. T-cell proliferation is critical for mounting an effective adaptive immune response. It is regula...
The Akt kinases promote hematopoietic cell growth and accumulation through phosphorylation of apopto...
The established role for phosphatidylinositol (3,4,5) triphosphate (PI(3,4,5)P3) signaling pathways ...
The immunosuppressant rapamycin (RAP) is a potent inhibitor of the entry of interleukin (IL)-2-stimu...
The phosphatidylinositol-3-OH kinase [PI(3)K] pathway is frequently activated in human cancers and r...
The phosphatidylinositol-3-OH kinase [PI(3)K] pathway is frequently activated in human cancers and r...
In T lymphocytes, the hematopoietic cytokine interleukin-2 (IL-2) uses phosphatidylinositol 3-kinase...
In T lymphocytes, the hematopoietic cytokine interleukin-2 (IL-2) uses phosphatidylinositol 3-kinase...
The macrolide rapamycin (RAP) is a potent inhibitor of interleukin-2 (IL- 2)-induced T-cell prolifer...
The established role for phosphatidylinositol (3,4,5) triphosphate (PI(3,4,5)P-3) signaling pathways...
<div><p>Currently, there is no efficient therapy for patients with peripheral T cell lymphoma (PTCL)...
The established role for phosphatidylinositol (3,4,5) triphosphate (PI(3,4,5)P3) signaling pathways ...
Currently, there is no efficient therapy for patients with peripheral T cell lymphoma (PTCL). The Pr...
Thesis (M.A.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Author...